Compounds > olaquindox
Page last updated: 2024-08-25

olaquindox and Carcinoma, Hepatocellular

olaquindox has been researched along with Carcinoma, Hepatocellular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, K; Chen, Q; Jin, X; Tang, S; Xiao, X; Zhang, T; Zou, J1
Jin, X; Liu, FY; Sun, CD; Tang, SS; Xiao, XL; Zhang, CM; Zhang, S; Zhang, T; Zhao, WX1

Other Studies

2 other study(ies) available for olaquindox and Carcinoma, Hepatocellular

ArticleYear
Olaquindox-induced genotoxicity and oxidative DNA damage in human hepatoma G2 (HepG2) cells.
    Mutation research, 2009, May-31, Volume: 676, Issue:1-2

    Topics: Carcinoma, Hepatocellular; Cell Survival; China; DNA; DNA Breaks; Dose-Response Relationship, Drug; Humans; Liver Neoplasms; Mutagenicity Tests; Oxidation-Reduction; Oxidative Stress; Quinoxalines; Reactive Oxygen Species

2009
c-Myc influences olaquindox-induced apoptosis in human hepatoma G2 cells.
    Molecular and cellular biochemistry, 2011, Volume: 354, Issue:1-2

    Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cytochromes c; Growth Substances; Humans; Proto-Oncogene Proteins c-myc; Quinoxalines; Reactive Oxygen Species; RNA Interference; Transcription, Genetic; Up-Regulation

2011